Real-World EGFR T790M Testing in Advanced Non-Small-Cell Lung Cancer: A Prospective Observational Study in Japan

INTRODUCTION: Approximately one-half of patients with epidermal growth factor receptor (EGFR) mutation-positive advanced/metastatic non-small-cell lung cancer (NSCLC) develop resistance to first- or second-generation EGFR tyrosine kinase inhibitors (TKIs) due to a secondary T790M mutation. This stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Seto, Takashi, Nogami, Naoyuki, Yamamoto, Nobuyuki, Atagi, Shinji, Tashiro, Naoki, Yoshimura, Yoko, Yabuki, Yutaka, Saka, Hideo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7359964/
https://www.ncbi.nlm.nih.gov/pubmed/32700028
http://dx.doi.org/10.1007/s40487-018-0064-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7359964/
https://www.ncbi.nlm.nih.gov/pubmed/32700028
http://dx.doi.org/10.1007/s40487-018-0064-8

Ejemplares similares